Pioneering PKU management
Prekulab’s mission is to improve the quality of PKU patients’ lives.
Established in 1970, the firm is a specialist in the field of PKU research and uses its substantial knowledge in the area to develop new solutions to help those affected by PKU and their families to lead as normal a life as possible.
Prekulab is a pioneer in the use of Large Neutral Amino Acids (LNAAs) which allow patients to eat a nearly normal diet. Prekulab makes five products, three using LNAAs (NeoPhe tablets and powder, plus PreKUnil tablets) and two using amino acid complexes (Avonil tablets and powder). Our LNNA products are clinically tested; tablets are developed by Prekulab with an advanced tablet-coating technique to make them easy to swallow, and are odour free and flavourless.
Prekulab’s team regularly attends PKU and metabolic disease conferences around the world and works with a strong network of global healthcare professionals to share knowledge and help make a difference in the life of people with PKU.
More information on Prekulab and its clinical research is available on the professionals page.